12th Risk Evaluation and Mitigation Strategies Summit (REMS)
January 21 - 22, 2020 - Arlington NY USExL Events, a division of Questex
ysheflyand@questex.com
Phone:0000000000
The 12th REMS Summit convenes pharma, FDA, healthcare providers, and patient advocates to delve into specific topics to enhance the understanding of when REMS are necessary the elements that need to be included in the REMS needed for their product, as well as details required for submission. Our adept speaking faculty will arm you with proven strategies to facilitate benefit-risk counseling, optimize REMS operations through streamlined health system integration, leverage interoperable technologies for consistent communication, and increase patient safety through cross-functional collaboration. Top Five Reasons to Attend: *To assess REMS efficacy with proven methods from industry professionals *Complying with regulations pertaining to standardization and evaluation *Collaborate with industry leaders on innovative approaches for REMS design, implementation, and solutions *Increase knowledge and awareness of upcoming REMS technologies, innovation and regulatory changes *Discussing the challenges of recent FDA guidelines impacting REMS Who Should Attend: This event is ideal for professionals from payers and pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas: REMS Risk Management Pharmacovigilance/Surveillance Quality Assurance Drug/Product Safety Clinical Risk Management Lifecycle Management Regulatory Affairs/Legal/Compliance Clinical Affairs Clinical Data Management Clinical Operations Clinical Risk Management Compliance Epidemiology/Pharmacoepidemiology Marketing